Stojšić, M.; Ležakov, O.; Ćeranić, S.; Stojšić, N.; Rajković, M.; Marković, S.; Kovačević, M.; Brkić, N.
TPMT and HLA-DQ Allelic Variants in Relation to Drug Response, Safety and Need for Therapy Optimization in Pediatric Inflammatory Bowel Disease. Children 2025, 12, 1334.
https://doi.org/10.3390/children12101334
AMA Style
Stojšić M, Ležakov O, Ćeranić S, Stojšić N, Rajković M, Marković S, Kovačević M, Brkić N.
TPMT and HLA-DQ Allelic Variants in Relation to Drug Response, Safety and Need for Therapy Optimization in Pediatric Inflammatory Bowel Disease. Children. 2025; 12(10):1334.
https://doi.org/10.3390/children12101334
Chicago/Turabian Style
Stojšić, Mirjana, Ognjen Ležakov, Sanja Ćeranić, Nikola Stojšić, Marko Rajković, Savina Marković, Milica Kovačević, and Nina Brkić.
2025. "TPMT and HLA-DQ Allelic Variants in Relation to Drug Response, Safety and Need for Therapy Optimization in Pediatric Inflammatory Bowel Disease" Children 12, no. 10: 1334.
https://doi.org/10.3390/children12101334
APA Style
Stojšić, M., Ležakov, O., Ćeranić, S., Stojšić, N., Rajković, M., Marković, S., Kovačević, M., & Brkić, N.
(2025). TPMT and HLA-DQ Allelic Variants in Relation to Drug Response, Safety and Need for Therapy Optimization in Pediatric Inflammatory Bowel Disease. Children, 12(10), 1334.
https://doi.org/10.3390/children12101334